After uniQure (QURE) announced they have achieved alignment with the FDA on key elements of an accelerated approval pathway for AMT-130, Stifel said this “looks like a best-case scenario,” noting that ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback